BioSpace News Archive

Business

Chubb Names Keith Higdon Division President of ESIS®, Inc.

Joe Vasquez to assume leadership role for Chubb Global Accident & Health

October 24, 2018
·
4 min read
Drug Development

Acerus Announces Initiation of a Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil

Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP) today announced first dosing of subjects in a Phase 1 clinical trial testing a proprietary intranasal formulation of a tetrahydrocannabinol (“THC”)-rich cannabis oil in healthy volunteers.

October 24, 2018
·
4 min read
Genetown

Institute for Clinical and Economic Review to Expand Deployment of New Health Economics Modeling Platform

Decision Follows Extensive Pilot Testing by Drug Pricing Watchdog

October 24, 2018
·
3 min read
Policy

Ra Medical Systems Appoints Dan Horwood as General Counsel

Ra Medical Systems, Inc. (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases, announced today that it has appointed Dan Horwood as General Counsel, effective immediately.

October 24, 2018
·
5 min read
Deals

Walgreens Boots Alliance Declares Regular Quarterly Dividend Payable on December 12, 2018

Walgreens Boots Alliance, Inc. today announced that its board of directors has declared a regular quarterly dividend of 44 cents per share, an increase of 10 percent over the year-ago period.

October 24, 2018
·
3 min read
Policy

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient’s menopausal status.

October 24, 2018
·
3 min read
Bio NC

IMPATHIQ’s EPIC integrated Chest pain management tool featured in Circulation publication

IMPATHIQ is pleased to announce that the American Heart Association journal Circulation has recently featured the company’s Heart Pathway point-of-care clinical decision support tool.

October 24, 2018
·
3 min read
Business

Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing

Dr. Geoffrey Shapiro and Dr. Timothy Yap bring extensive expertise in targeting cell-cycle and DNA repair mechanisms in oncology drug development

October 24, 2018
·
9 min read
BioMidwest

Survey Finds 38% of Parents Say Their Children Experience Anxiety

Nearly two in five (38 percent) parents say their child suffers from anxiety, according to a new survey commissioned by the American Osteopathic Association and conducted online by The Harris Poll.

October 24, 2018
·
4 min read
Voluntis Announces End of Multi-Cancer Extension for Solution Developed with Roche Pharma France

Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960) (Paris:VTX), a company specializing in digital therapeutics, announces Roche Pharma France’s decision to end the agreement, announced in March 2018, to extend the ZEMY solution, initially developed in breast cancer, to all solid tumors.

October 24, 2018
·
1 min read